INTRODUCTIONTranscatheter aortic valve replacement (TAVR) is recommended in patients with symptomatic severe aortic valve stenosis (AS) and an elevated surgical risk , and is serving a growing proportion of patients . As with surgical aortic valve replacement TAVR comes with a 30‐day major stroke rate of approximately 2–5% . TAVR requires large bore catheter navigation through the arterial vasculature and the implantation of a bioprosthesis within a degenerated aortic valve, which may provoke intraprocedural tissue dislodgment. Indeed, transcranial Doppler, brain magnetic resonance imaging (MRI) and histopathology studies suggest cerebral embolization in the vast majority of TAVR procedures . Silent brain lesions and (micro‐) infarcts may not be trivial, as they are associated with neurocognitive deterioration .Dedicated deflecting and filter‐based devices were designed to reduce cerebral embolization. The DEFLECT‐III trial demonstrated fewer ischemic brain lesions and preserved neurocognition with the TriGuard deflector . The Sentinel transcatheter cerebral embolic protection (TCEP) device (Claret medical, Santa Rosa, CA) provides filters to the brachiocephalic trunk and the left common carotid artery and thus omits the left vertebral artery. Recent studies demonstrated debris capture in almost all patients undergoing TAVR with Sentinel TCEP . Three randomized trials compared brain‐MRIs several days after TAVR in
Catheterization and Cardiovascular Interventions – Wiley
Published: Jan 1, 2018
Keywords: ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera